MARKET

VRAX

VRAX

Virax Biolabs Group Ltd
NASDAQ
0.7000
+0.0364
+5.49%
After Hours: 0.7172 +0.0172 +2.46% 19:20 04/25 EDT
OPEN
0.7020
PREV CLOSE
0.6636
HIGH
0.7020
LOW
0.6602
VOLUME
8.50K
TURNOVER
0
52 WEEK HIGH
5.45
52 WEEK LOW
0.6133
MARKET CAP
1.65M
P/E (TTM)
-0.4659
1D
5D
1M
3M
1Y
5Y
Virax Biolabs Debuts ImmuneSelect Portfolio
TipRanks · 22h ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Processa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. Cyclacel Pharmaceuticals stock rose 23.04% and Compass Therapeutics shares rose 21.62%. Can Fite Biofarma (AMEX:CANF) stock also moved upwards.
Benzinga · 23h ago
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes
Virax Biolabs launches 'ImmuneSelect' for post-viral syndromes. The ImmuneSelect portfolio includes peptide pools for SARS-CoV-2, Lyme Disease, and Epstein-Barr Virus. The products are for research and investigational use only and not intended to be used as a diagnostic tool.
Benzinga · 23h ago
Weekly Report: what happened at VRAX last week (0415-0419)?
Weekly Report · 4d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Trevena (NASDAQ:TRVN) shares increased by 27.0% to $0.51 during Wednesday's after-market session. Mustang Bio stock increased by 11.97% and SINTX Techs stock rose 10.32% in the same session. Losers TRACON Pharma and DIH Holding US stock fell by 16.6% and 14.05% respectively.
Benzinga · 04/17 20:31
Virax Biolabs Showcases Innovations at ESCMID 2024
TipRanks · 04/16 11:57
Weekly Report: what happened at VRAX last week (0408-0412)?
Weekly Report · 04/15 10:57
Weekly Report: what happened at VRAX last week (0401-0405)?
Weekly Report · 04/08 11:01
More
About VRAX
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against global viral threats. Its product portfolio includes ViraxClear and Virax Immune. ViraxClear offers a range of accurate diagnostic testing kits and machines. Virax Immune is a new Covid-19 test seeking detection of T-Cell immune responses to the SARS-Cov-2 virus. Its T-Cell testing is effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Monkeypox, Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Webull offers Virax Biolabs Group Ltd stock information, including NASDAQ: VRAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRAX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRAX stock methods without spending real money on the virtual paper trading platform.